PD-L1, an immunoinhibitory receptor that was first described in 1992 by Ishida, is expressed in tumor cells and various types of immune cells, including activated B cells and T cells, macrophages, and dendritic cells [8, 39]. Here, CD274 is linked to neoplasm.